chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot #024LM20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medicines were not reported.
Runny Nose Chest, Nose, Ear congestion, inflammation: throat Fluid in ears Dry unproductive cough, tan/yellow sputum
Patient presented to the ER via ambulance on 3/22/21 with a 5-6 day history of increasing shortness of breath. Patient is on home oxygen 2 L prior to admit. Patient hypoxic at home by EMS was 88% on 2L
High fever with 4 hours of vaccines. TM 104 degrees. Hospitalized. Found to have UTI.
A Fluzone HD vaccine was administered to a 61 year old woman.  Fluzone HD is approved for ages 65 and up.
This case was reported by a nurse via call center representative and described the occurrence of adverse reaction in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis. Previously administered products included ENGERIX B vaccine with an associated reaction of prophylaxis (received on an unknown date refer case, US2019034223). On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were reported as follows: The age at the vaccination was not reported. Nurse reporting the patient can't get flu shot unless she receives a hypoallergenic flu shot. She does not know if patient had previous reaction to a flu shot. Nurse stated, at the time of initial report, she was unable to find other details related to patient's flu vaccine details, including where she received vaccine, injection site location, lot number, expiration date, brand of flu vaccine and the physician.
metallic taste, hot trachea and esophagus, breathing difficulty, diarrhea, fatigue, extreme headache, sensitivity to light
Mother describe a "bouncy ball size" welt with redness and rash around the right upper leg at injection site the next morning after the vaccine was given, including fussiness.  Mother was asked if any, difficulty breathing, fever or any other symptoms. No other symptoms.  Mother gave fever reducing oral liquid drops for any discomfort. Mother claimed she (mother) also has adverse reaction in her medical history to Dtap
Joint pain, aches, headache, chills, fever and injection site soreness.  Began night of vaccination and lasted one full day after with slight residual for 2 additional days.  All subsided within 3 days.
"A PA reported that a 2 month old male, post vax on 11/30/98, vomited twice. He was seen by the reporter who, prescribed Pedialyte. The infant was seen again on 12/3/98, because he had developed watery diarrhea (3-4 watery brown stools per day), which began on 11/30/98, after leaving the office. The infant's formula was changed from Similac to Isomil. On 12/4/98, the mother reported that the infant had 1 firm stool. On 12/7/98, the mother reported that the infant recovered."
A few days after my vaccine, I developed a maculopapular rash on arms, torso, legs, around 50% of body. Tried Benadryl without response. Tried topical hydrocortisone without response. Finally resolved with physician prescription of clobestasol. No other inciting cause could be identified. Consulted also with derm as well.
Six days post vax the pt had an allergic reaction with rash. These symptoms resolved. 24 hours subsequent to receiving second dose of Engerix B the pt again experienced a rash. The rash is improved but skin is still bumpy. The pt was treated with steroid cream and Benadryl Engerix B was discontinued. The most recent information received, reports the condition of the pt is ongoing.
This spontaneous report was received from a Medical Assistant referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patient was vaccinated with an expired dose of M-M-R II 0.5 ml, subcutaneous, lot # M045101, expiration date on: 10-NOV-2018 (anatomical location was not provided) for prophylaxis. Concomitant therapies included sterile diluent(manufacturer unknown), however no adverse events reported.
Patient complained of severe cold chills. Upon morning raising patient experienced dizzyness and fatigue. Went back to bed and after nap felt better to resume normal activities.
Lymph node swelling by right side collarbone. Was pretty tender for nearly a week.  And general marked fatigue for ~10-14 days afterwards.
Patient reported to pharmacy on 10/13 morning with swollen arm to elbow, redness, warm to touch in right arm. She had take some Tylenol for pain. She was concerned about redness, swelling. Pharmacist advised her to take ibuprofen today for swelling but she preferred Tylenol. Pharmacist will call to check on patient on evening of 10/13.
Following day, minor soreness & numbness of upper left arm Day 3, continued numbness of arm & also shoulder area As of May 3rd, numbness still present along with some tightness on left side of neck
PAIN IN RIGHT ARM. PATIENT TAKE TYLENOL #4 ALREADY. PATIENT CAME TO PHARMACY 6/24/23 AND ALERTED PHARMACIST OF ONGOING PAIN THAT SHE BELIEVES IS FROM PREVNAR 20 VACCINE RECEIVED ON 10/1/22.
Redness and induration on the left arm at site of injection, induration measured 70 x 80 mm, arm warm to touch. Patient reports itchiness and pain at site. Symptoms began after summer school 7/29/14, father applied ice on and off but no change in swelling.
Patient was due for her 4 year old shots (MMR, Varivax, IPV, and DTap).  Patient actually received MMR, Varivax, Kinrix (DTap, IPV), and additional DTap in error.  This was realized after the visit.  Mom notified over the phone to be made aware of the situation and apologize for our mistake.  Mom verbalized understanding and reports patient is feeling well with no current symptoms.  Advised she is UTD, but given that she got two doses of DTap, she may experience more localized soreness/swelling, fever, and localized pain. Advised to give Motrin/Tylenol PRN if she has any of these symptoms.  Return precautions given. Mom verbalized understanding and in agreement with plan of care.
Itchy watery red eyes, my chest was tighten, breast and nipples harden, throat was tighten, couldn't breathe as easy, and tongue was swollen.
COUGHING; CONGESTION; CANNOT WALK DUE TO WEAKNESS; ACHING; VERTIGO; DIFFICULTY GETTING UP AND NEED ASSISTANCE TO GET UP / CANNOT SUPPORT HERSELF; EXTREME WEAKNESS IN LEGS; WEAKNESS; HIGH FEVER; This spontaneous report received from a consumer concerned a 75 year old female. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: 19-SEP-2021) dose was not reported, administered on 17-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 18-AUG-2021, the patient experienced coughing. On 18-AUG-2021, the patient experienced congestion. On 18-AUG-2021, the patient experienced cannot walk due to weakness. On 18-AUG-2021, the patient experienced aching. On 18-AUG-2021, the patient experienced vertigo. On 18-AUG-2021, the patient experienced difficulty getting up and need assistance to get up / cannot support herself. On 18-AUG-2021, the patient experienced extreme weakness in legs. On 18-AUG-2021, the patient experienced weakness. On 18-AUG-2021, the patient experienced high fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from coughing, congestion, high fever, weakness, cannot walk due to weakness, aching, vertigo, extreme weakness in legs, and difficulty getting up and need assistance to get up / cannot support herself. This report was non-serious.
This was my booster. Starting April 10th, I began to feel heart palpitations, unrelated to activity/diet/behavior. They would come and go throughout the day (we were out of town). When we returned home on the 16th, I took my blood pressure with a home cuff and it was normal.  The symptoms were slowly subsiding (frequency of palpitations lessening) and then the first week in May I began with an itchy sensation. Ironically the palpitations completely stopped. The itch was first on my calves. There was no change in detergent/soaps/environment, and the itch would start, and eventually subside within 20 min or so.  Then I would be OK and the itchy sensation would return, sometimes in an hour, sometimes in four. This happened daily with the sites being variable (back of calves, back of knees, thigh, inner thigh, forearm).  On May 7th, I woke with an excruciating sore throat and the itchy sensation completely disappeared. I also bean to feel nauseous, and food began to be metallic in flavor. I took two rapid tests for COVID, and both were negative. The sore throat is subsiding today, May 9th, and the taste is still not what it was. The itchy sensation is also gone. Overall I am just tired.
Pt received Moderna dose #1 without any complications.  Before giving the shot I normally (80-90% of the time) tell the pt which manufacturer's vaccine is being given but due to the hectic conditions at the time that was not done.  When scheduling 2nd dose pt learned it was Moderna and became extremely upset; claiming she wanted Pfizer.  At no point did pt communicate that to anyone in pharmacy.
Red over injection site that spread, intense itching over entire body,  elevated temp, chest pain sweats, candida infection in groin,  Used benedryl and oxygen already in home and soda baths, meds listed on usually used medications. Lasted for 5 days with gradual relief.
First dose / November 2019 / has not received the second / yet due to Covid pandemic; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in November 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, the patient did not received the second dose yet due to covid pandemic, which led to social problem. The reporter consented to follow up.
This spontaneous report as received from a physician via company representative refers to a male patient of unknown age. On 28-JUN-2017 the patient was vaccinated with GARDASIL 9 (dose, lot number and route were not reported) for prophylaxis. On 29-JUN-2017, the patient experienced penis disorder and dysuria. The outcome of penis disorder and dysuria was unknown. Causality was not reported. Additional information has been requested.
felt like he got wallaped in the left injection site arm with both Moderna Covid-19 vaccines.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (felt like he got wallaped in the left injection site arm with both Moderna Covid-19 vaccines.) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (felt like he got wallaped in the left injection site arm with both Moderna Covid-19 vaccines.). At the time of the report, VACCINATION SITE REACTION (felt like he got wallaped in the left injection site arm with both Moderna Covid-19 vaccines.) outcome was unknown.            Concomitant medications details were not reported. Treatment details was not reported.   This case was linked to MOD-2021-361603 (Patient Link).
SWOLLEN HANDS; SORES ON KNUCKLES; This spontaneous report received from a patient concerned an adult female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. It was unknown if patient was pregnant.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, one total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included golimumab. On an unspecified date, the patient was hospitalized for unspecified days, with complaint of  swollen hands, sores on knuckles and was on wheelchair. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sores on knuckles and swollen hands was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220337665-COVID-19 VACCINE AD26.COV2.S-sores on knuckles. This event(s) is labeled per RSI and is therefore considered potentially related.  20220337665-COVID-19 VACCINE AD26.COV2.S-swollen hands. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Headache; Fever; Chills; injection site soreness; Rash on inside of right thigh. Rash on left side of waist on the back side.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in left arm on 19Mar2021 at 10:30 (61-year-old at the time of vaccination) as a single dose for COVID-19 immunisation. Medical history included cardiac artery disease. The patient had allergy to shrimp. Concomitant medications included atenolol (MANUFACTURE UNKNOWN), PLAVIX and CRESTOR for unknown indications from unknown dates. Patient had not tested positive for COVID-19 since having the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 01:00, the patient experienced headache, fever, chills, injection site soreness, rash on inside of right thigh and rash on left side of waist on the back side. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, fever, chills, injection site soreness, rash on inside of right thigh and rash on left side of waist on the back side were not recovered.   No follow up attempts are needed. No further information is expected.
Foggy/dizzy almost immediately following vaccination, sever chills that lasted for hours overnight, fever of 102.1 (brought down with Tylenol, it remained at or a over 100 for 8 more hours), nausea, headache
She had a quick test through finger blood sample resulting positive. She received first dose of Pfizer's COVID-19 vaccine 9 days ago; This is a spontaneous report from a non-contactable consumer, the patient. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via unspecified route of administration on an unknown date in Mar2021 as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she received first dose of Pfizer's COVID-19 vaccine 9 days ago (in Mar2021) and yesterday (in Mar2021) she had a quick test through finger blood sample resulting positive. The clinical outcome for the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A non-serious spontaneous report of "got H1N1 LAIV, then realized that she is pregnant" was received from a physician concerning a 41-year-old female, subsequent to H1N1, Intranasal. The patient had no medical history. The obstetrical history included gravida two and para one. The patient was not pregnant at the time of vaccination. The LMP date was reported as on or around 10-Oct-2009 whereas expected date of delivery has been reported as 17-Jul-2010. The patient was not on any concomitant medications. The patient received the vaccine during the first few days of Oct-2009 for an unknown indication. The patient delivered a baby on around16 or 17-Jul-2010. The baby was fine and there were no problems. There was no adverse event associated with this pregnancy. Treatment and reporter causality assessments are not applicable. The outcome of vaccine exposure before pregnancy was considered resolved. Additional information received on 07-Jan-2010 and incorporated in narrative: Patient's medical and obstetrical history, concomitant medications, adverse event information. As the vaccination date is before the LMP date, coding was changed to 'vaccine exposure before pregnancy'. Other additional information received: Patient initials, date of birth and vaccination date. Additional information received on 31-Aug-2010 and incorporated in narrative: Outcome of the pregnancy. The patient delivered a baby on around 16 or 17-Jul-2010. Other additional information received: Patient's name. Corrected patient's initials.
Left arm sore for three days.  On 4th day there was a lump at injection site entire area surrounding site becane res, swollen, warm, and very itchy.   On morning of 3/17  had a fever of 102 degrees and redness began to migrate down arm
patient received dose 1 as Moderna and dose 3 as BNT162B2; She had serious neck pain.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Sep2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 67 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "head injury ", "She had these neurologic side effects as well happen with the first ones she received."; Covid-19 vaccine (DOSE 2, SINGLE, Manufacturer unknown), for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "not recovered", described as "patient received dose 1 as Moderna and dose 3 as BNT162B2"; NECK PAIN (non-serious), outcome "not recovered" and all described as "She had serious neck pain.".  Additional information: She mentioned the previous vaccines she had was the Moderna Covid Vaccine. She had these neurologic side effects as well happen with the first ones she received. The first vaccines she received was the Moderna.  She wonders if now and believes she is having side effects from mixing both the Moderna and Pfizer vaccines. She has had two subsequent vaccines and booster. She clarify neurologic side effects after getting the Pfizer Covid-19 Bivalent 12 year plus vaccine. She had serious neck pain. The serious neck pain was so painful she has to use two pillows to sleep on to  elevate her head. The pain is all around her entire neck; the is pain so bad.  This started within the week of getting the vaccine.  Reporter mentioned she is expecting a call from her provider to discuss the side effects  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient received BNT162b2 (BNT162B2), on 26Sep2021 as dose number unknown, single (Lot number: EL0185) at the age of 45 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma (exercise induced)" (unspecified if ongoing), notes: Asthma (exercise induced). The patient's concomitant medications were not reported. Past drug history included: Aspirin, reaction(s): "Allergic to: Aspirin", notes: known allergies Allergic to: Aspirin, pepcid; Pepcid, reaction(s): "Allergic to: pepcid", notes: known allergies Allergic to: Aspirin, pepcid. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
diagnosed with large t cell lymphoma. swollen glands in neck presented  in October. Went to urgent care and biopsy showed lymphoma.
This spontaneous report was received from a medical assistant regarding unspecified number of patients of unknown age and gender. Patient demographics were not provided. Information on their concurrent conditions, pertinent medical history and drug allergies were not reported. On an unknown date the patients were vaccinated with improperly stored and VARIVAX (Merck) lot #L002217, expiry date 21-JAN-2017 (dose, route and anatomical location were not reported) (incorrect product storage). No adverse effects were reported. Product storage temperature was 18 F, for a time frame of 30 minutes, there were previous administered excursions reported, 6 F for 10 hours and 5 minutes. Additional information has been requested.
Information has been received from a Registered Nurse concerning a 53 year old female with a history of asthma and no drug allergies who was vaccinated SC with a 0.5 mL dose of PNEUMOVAX 23 (lot # 665400/1315Y) on 27-APR-2010 developed an injection site reaction including itching, swelling and pain. The patient called the office on 28-APR-2010 regarding her symptoms and she was told to treat the area with ice and over-the-counter anti-inflammatories. On unspecified date, the patient recovered. The patient had been vaccinated with a dose of PNEUMOVAX "10 years ago". Additional information has been requested.
Patient developed pain and swelling in Left leg on 4/5/21.  He first noticed it when he was swimming and felt a cramp to his leg.  Over time it began hurting when he walked on it.  He has had no shortness of breath or trouble breathing except for a brief time while he was swimming and felt as if he was slightly shorter of air than normal.    Patient was positive for DVT and started on Xarelto